Back

Impact of cardiovascular co-morbidities on all-cause mortality in lung, breast, prostate and bowel cancer

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Cardiovascular risk in populations Epidemiology, lipids ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Paul Richard Carter

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

18 More presentations in this session

Presentation thumbnail
Similar high distance to recommended LDL-cholesterol-targets despite chronic statin treatment in Europe, Canada, Middle East, Africa and Asia - Results of DYSIS
Doctor A. Gitt (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
Prevalence of elevated LDL- cholesterol and the risk of cardiovascular events in a population with established atherosclerotic cardiovascular disease, type 2 diabetes and metabolic dyslipidemia
Doctor J. Rana (Oakland, US)
Abstract Slides
Presentation thumbnail
Trends in high-intensity statin therapy after myocardial infarction, 2011-2014
Professor R. Rosenson (New York City, US)
Abstract
Presentation thumbnail
Cardiovascular events of patients presenting with peripheral artery disease (PAD): an epidemiological analysis using a claims database in France
Professor A. Bura Riviere (Toulouse, FR)
Abstract Slides
Presentation thumbnail
Changes in the epidemiology of acute coronary syndromes during a decade
Doctor G. Thorgeirsson (Reykjavik, IS)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Cardiovascular risk in populations

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources